Entry Name Natural killer cell mediated cytotoxicity - Camelus dromedarius (Arabian camel)
Description Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
Class Organismal Systems; Immune systemBRITE hierarchy
Pathway map cdk04650 Natural killer cell mediated cytotoxicity
Ortholog table Other DBs Organism Camelus dromedarius (Arabian camel) [GN:
cdk ]
Gene 105106334 LOW QUALITY PROTEIN: putative killer cell immunoglobulin-like receptor like protein KIR3DP1 [KO:K07980 ]
105085620 VAV3; guanine nucleotide exchange factor VAV3 isoform X1 [KO:K05730 ]
105102810 VAV2; LOW QUALITY PROTEIN: guanine nucleotide exchange factor VAV2 [KO:K05730 ]
105101582 RAC2; ras-related C3 botulinum toxin substrate 2 isoform X1 [KO:K07860 ]
105102215 RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861 ]
105090018 CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427 ]
105105185 low affinity immunoglobulin gamma Fc region receptor III isoform X1 [KO:K06463 ]
105106332 natural cytotoxicity triggering receptor 1 isoform X2 [KO:K06741 ]
105087519 NCR3; LOW QUALITY PROTEIN: natural cytotoxicity triggering receptor 3 [KO:K06743 ]
105100105 FCER1G; high affinity immunoglobulin epsilon receptor subunit gamma [KO:K07983 ]
105092725 CD247; T-cell surface glycoprotein CD3 zeta chain isoform X1 [KO:K06453 ]
105102785 LAT; linker for activation of T-cells family member 1 isoform X1 [KO:K07362 ]
105089682 LAT2; linker for activation of T-cells family member 2 isoform X1 [KO:K26356 ]
105085024 PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116 ] [EC:3.1.4.11 ]
105089440 PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 isoform X1 [KO:K05859 ] [EC:3.1.4.11 ]
105086305 PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922 ] [EC:2.7.1.153 ]
105107003 PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [KO:K00922 ] [EC:2.7.1.153 ]
105085928 PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922 ] [EC:2.7.1.153 ]
105084758 PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649 ]
105101867 PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649 ]
105092913 phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649 ]
105093416 SHC2; LOW QUALITY PROTEIN: SHC-transforming protein 2 [KO:K17447 ]
105086410 SHC3; LOW QUALITY PROTEIN: SHC-transforming protein 3 [KO:K17448 ]
105091467 SOS2; LOW QUALITY PROTEIN: son of sevenless homolog 2 [KO:K03099 ]
105094219 KLRK1; NKG2-D type II integral membrane protein isoform X1 [KO:K06728 ]
105088066 HCST; hematopoietic cell signal transducer isoform X2 [KO:K07988 ]
105102643 PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
105092463 PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
105089593 PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348 ] [EC:3.1.3.16 ]
105103850 NFATC1; LOW QUALITY PROTEIN: nuclear factor of activated T-cells, cytoplasmic 1 [KO:K04446 ]
105105081 NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X4 [KO:K17332 ]
105085942 TNFSF10; tumor necrosis factor ligand superfamily member 10 [KO:K04721 ]
105102505 tumor necrosis factor receptor superfamily member 10B-like isoform X1 [KO:K04722 ]
105102515 tumor necrosis factor receptor superfamily member 10A-like isoform X1 [KO:K04722 ]
105092770 FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389 ]
105102832 FAS; tumor necrosis factor receptor superfamily member 6 isoform X1 [KO:K04390 ]
105100737 BID; LOW QUALITY PROTEIN: BH3-interacting domain death agonist [KO:K04726 ]
Compound C01245 D-myo-Inositol 1,4,5-trisphosphate
C05981 Phosphatidylinositol-3,4,5-trisphosphate
Reference Authors Chiesa S, Tomasello E, Vivier E, Vely F.
Title Coordination of activating and inhibitory signals in natural killer cells.
Journal Reference Authors Maghazachi AA.
Title Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
Journal Reference Authors Vivier E, Nunes JA, Vely F.
Title Natural killer cell signaling pathways.
Journal Reference Authors Colucci F, Di Santo JP, Leibson PJ.
Title Natural killer cell activation in mice and men: different triggers for similar weapons?
Journal Reference Authors Perussia B.
Title Signaling for cytotoxicity.
Journal Reference Authors Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
Title Activation of NK cell cytotoxicity.
Journal Reference Authors Djeu JY, Jiang K, Wei S.
Title A view to a kill: signals triggering cytotoxicity.
Journal Clin Cancer Res 8:636-40 (2002)
Reference Authors Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
Title Nature's TRAIL--on a path to cancer immunotherapy.
Journal Reference Authors Colonna M.
Title Fine-tuning NK cell responses: it's a family affair.
Journal Reference Authors Bonnema JD, Leibson PJ.
Title Signal transduction during NK cell activation.
Journal Chem Immunol 64:28-43 (1996)
Reference Authors Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
Title Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
Journal Reference Authors Rao A, Luo C, Hogan PG.
Title Transcription factors of the NFAT family: regulation and function.
Journal Reference Authors Wu J, Lanier LL.
Title Natural killer cells and cancer.
Journal Reference Authors Cerwenka A, Lanier LL.
Title Natural killer cells, viruses and cancer.
Journal Reference Authors Blott EJ, Griffiths GM.
Title Secretory lysosomes.
Journal Reference Authors Lieberman J.
Title The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
Journal Reference Authors Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
Title Granzyme B: a natural born killer.
Journal Reference Authors Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
Title Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
Journal Reference Authors Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
Title Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
Journal J Immunol 161:6648-56 (1998)
Reference Authors Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
Title Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
Journal Related cdk04060 Cytokine-cytokine receptor interaction
KO pathway LinkDB All DBs
